01194nas a2200181 4500000000100000008004100001260001200042653001300054653002700067653001300094100001500107700001400122700001200136245009800148856010400246520064800350022001400998 2021 d c01/202110aTrachoma10aElimination strategies10aCovid-191 aEmerson PM1 aHooper PJ1 aGebre T00aUse of modelling to modify trachoma elimination strategies affected by the COVID-19 pandemic. uhttps://academic.oup.com/trstmh/advance-article-pdf/doi/10.1093/trstmh/traa175/35589681/traa175.pdf3 a

Models predict that the negative effects of delayed implementation in trachoma elimination programmes caused by the COVID-19 pandemic will be minimal, except in high prevalence districts where progress may be reversed. During times of change we must stand by our principles of evidence-based decision-making, but also be willing to show flexibility. Slow progress to elimination in high prevalence districts was already a significant challenge to the global programme and mitigation of COVID-related delays with enhanced implementation provides an opportunity to simultaneously address an unprecedented challenge and a pre-existing one.

 a1878-3503